ADVFN US – Market Content Editor
-
NextNRG Shares Gain on Planned Acquisition of Canadian Fuel Logistics Firm
NextNRG Inc. (NASDAQ:NXXT) shares climbed 6.5% following the announcement of its intention to acquire ReFuel Mobile, a profitable mobile fueling provider based in Ontario, Canada. The deal, outlined in a non-binding letter of intent, would give NextNRG 100% ownership of ReFuel, with payment to be made either in cash or in restricted common shares, depending…
-
Joby Aviation Shares Climb After Successful Piloted Test Flights in Dubai
Joby Aviation, Inc. (NYSE:JOBY) saw its stock jump 6.75% after announcing the successful completion of piloted, wingborne vertical takeoff and landing (VTOL) flights in Dubai, a key step in the company’s path to launching commercial operations. The electric air taxi manufacturer delivered its first aircraft to the United Arab Emirates under a strategic collaboration with…
-
Avadel Stock Climbs as Appeals Court Backs FDA Approval of LUMRYZ
Shares of Avadel Pharmaceuticals PLC (NASDAQ:AVDL) rose 4.7% following a key legal victory, as a U.S. appeals court unanimously upheld the FDA’s approval of LUMRYZ, the company’s once-nightly treatment for narcolepsy. The decision marks a significant step forward in Avadel’s efforts to solidify its presence in the sleep disorder treatment space. The U.S. Court of…
-
BitMine Stock Skyrockets on $250M Private Placement to Back Ethereum Strategy
Shares of BitMine Immersion Technologies (AMEX:BMNR) surged 180% after the company unveiled a $250 million private placement aimed at executing a bold Ethereum-centric treasury strategy. The initiative could position BitMine among the largest publicly traded holders of Ethereum (ETH). The funding round includes the sale of 55,555,556 common shares priced at $4.50 each, targeting gross…
-
Moderna Shares Climb on Strong Phase 3 Results for Flu Vaccine Candidate
Moderna Inc (NASDAQ:MRNA) saw its stock rise 3.8% after announcing that its experimental flu vaccine, mRNA-1010, delivered positive results in a Phase 3 clinical trial, showing greater efficacy than standard influenza vaccines. In adults aged 50 and older, the mRNA-based vaccine candidate demonstrated a relative vaccine efficacy of 26.6% against influenza illness when compared to…
-
Rocket Pharmaceuticals Shares Gain on FDA Green Light for Gene Therapy Targeting Heart Failure
Shares of Rocket Pharmaceuticals Inc (NASDAQ:RCKT) advanced 2.4% after the company announced that the U.S. Food and Drug Administration has approved its Investigational New Drug (IND) application for RP-A701, a gene therapy aimed at treating BAG3-associated Dilated Cardiomyopathy (DCM). The regulatory green light represents a major development for Rocket’s pipeline of cardiovascular gene therapies. RP-A701…
-
U.S. Markets Open Strong on Monday, June 30, 2025: Stocks Rise on Trade Hopes and Rate Cut Expectations
U.S. stock markets opened higher on Monday, ending June on a strong note thanks to optimism around trade deals and potential interest rate cuts. As of 9:35 AM ET: All three major indexes are set for solid monthly gains, boosted by a new trade deal between the U.S. and China. This raises hopes that more…
-
Dow Jones, S&P, Nasdaq, Wall Street Futures Point Higher Amid Trade Optimism, Major Indexes Eye Continued Gains
U.S. stock futures are signaling a positive start on Monday, suggesting that equities could extend their gains after a mostly upbeat but volatile session to close last week. The growing optimism around potential trade agreements is fueling the upward trend, as investors anticipate the upcoming deadline for reciprocal U.S. tariffs scheduled for early next month.…
-
Tempus AI Shares Drop Following Announcement of $400 Million Convertible Notes Offering
Tempus AI (NASDAQ:TEM) shares declined 2.6% after the precision medicine technology firm revealed plans for a $400 million offering of convertible senior notes due in 2030. The Chicago-based company aims to use part of the proceeds to repay existing term loans, including immediately settling its $275 million 2027 term loan. This repayment is expected to…
-
Zscaler Stock Drops Following Announcement of $1.5 Billion Convertible Bond Offering
Shares of Zscaler (NASDAQ:ZS) declined over 3% in premarket trading Monday after the cloud security company revealed plans to raise $1.5 billion by issuing convertible bonds with a three-year maturity. The firm intends to use part of the proceeds to purchase capped calls—financial instruments that help limit dilution risk when bonds convert to shares. The…